Total Payments
$50,892
2024 Payments
$710.15
Companies
54
Transactions
399
Medicare Patients
1,921
Medicare Billing
$379,697
Payment Breakdown by Category
Consulting$44,208 (86.9%)
Food & Beverage$6,084 (12.0%)
Education$348.09 (0.7%)
Travel$252.42 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $44,208 | 7 | 86.9% |
| Food and Beverage | $6,084 | 371 | 12.0% |
| Education | $348.09 | 20 | 0.7% |
| Travel and Lodging | $252.42 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $42,169 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,737 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $416.42 | 29 | $0 (2024) |
| Lilly USA, LLC | $414.99 | 29 | $0 (2020) |
| PFIZER INC. | $344.08 | 28 | $0 (2024) |
| Genentech USA, Inc. | $331.81 | 26 | $0 (2020) |
| Amgen Inc. | $322.58 | 18 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $305.00 | 9 | $0 (2020) |
| PUMA BIOTECHNOLOGY, INC. | $297.97 | 5 | $0 (2021) |
| Clovis Oncology, Inc. | $258.19 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $710.15 | 38 | Daiichi Sankyo Inc. ($221.50) |
| 2023 | $609.83 | 52 | Daiichi Sankyo Inc. ($369.91) |
| 2022 | $358.63 | 39 | Daiichi Sankyo Inc. ($233.60) |
| 2021 | $1,212 | 5 | Daiichi Sankyo Inc. ($1,028) |
| 2020 | $43,981 | 28 | Daiichi Sankyo Inc. ($40,161) |
| 2019 | $1,219 | 92 | Genentech USA, Inc. ($160.67) |
| 2018 | $2,235 | 115 | Clovis Oncology, Inc. ($237.20) |
| 2017 | $566.08 | 30 | Millennium Pharmaceuticals, Inc. ($91.10) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Hematology/Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Oncology | ||||||
| 07/23/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/11/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.04 | General |
| 05/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 05/14/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 05/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/01/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Oncology | ||||||
| 04/19/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 478 | 3,017 | $229,184 | $59,940 |
| 2022 | 20 | 546 | 1,836 | $312,061 | $98,258 |
| 2021 | 17 | 519 | 2,358 | $283,082 | $116,697 |
| 2020 | 15 | 378 | 16,334 | $269,933 | $104,801 |
Total Patients
1,921
Total Services
23,545
Medicare Billing
$379,697
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 17 | 52 | $5,200 | $1,321 | 25.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,400 | $1,249 | 28.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 24 | 75 | $4,500 | $817.92 | 18.2% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 15 | 420 | $21,840 | $701.88 | 3.2% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2021 | 11 | 18 | $1,242 | $365.12 | 29.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 19 | 610 | $3,050 | $70.18 | 2.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 11 | 44 | $220.00 | $65.80 | 29.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2021 | 13 | 40 | $400.00 | $28.64 | 7.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 57 | 307 | $49,120 | $48,819 | 99.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 220 | $60,500 | $17,604 | 29.1% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2020 | 13 | 14,250 | $42,750 | $12,103 | 28.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 19 | 94 | $38,728 | $10,070 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 120 | $21,000 | $6,356 | 30.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $6,500 | $2,107 | 32.4% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 12 | 79 | $7,900 | $1,960 | 24.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2020 | 12 | 430 | $22,360 | $1,491 | 6.7% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 12 | 13 | $3,575 | $1,173 | 32.8% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 14 | 88 | $6,160 | $1,155 | 18.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 13 | 19 | $3,610 | $1,047 | 29.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 23 | 73 | $4,380 | $743.95 | 17.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 15 | 66 | $330.00 | $91.30 | 27.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 13 | 520 | $2,600 | $52.96 | 2.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 11 | 42 | $420.00 | $27.19 | 6.5% |
About Dr. Deepna Jaiswal, D.O
Dr. Deepna Jaiswal, D.O is a Hematology & Oncology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1447541594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepna Jaiswal, D.O has received a total of $50,892 in payments from pharmaceutical and medical device companies, with $710.15 received in 2024. These payments were reported across 399 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($44,208).
As a Medicare-enrolled provider, Jaiswal has provided services to 1,921 Medicare beneficiaries, totaling 23,545 services with total Medicare billing of $379,697. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Plano, TX
- Active Since 04/25/2011
- Last Updated 02/06/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447541594
Products in Payments
- Enhertu (Drug) $41,392
- INJECTAFER (Drug) $619.95
- Rubraca (Drug) $258.19
- ZEJULA (Drug) $194.92
- XTANDI (Drug) $184.89
- VERZENIO (Drug) $182.18
- NINLARO (Drug) $172.84
- Nerlynx (Drug) $162.04
- VELCADE (Drug) $156.44
- NERLYNX (Drug) $135.93
- AFINITOR (Drug) $135.54
- LYNPARZA (Drug) $134.91
- ENHERTU (Drug) $127.82
- OPDIVO (Biological) $117.97
- Nplate (Biological) $117.46
- BOSULIF (Drug) $109.68
- KEYTRUDA (Biological) $107.66
- JEVTANA (Drug) $107.38
- Neulasta (Biological) $101.49
- IBRANCE (Drug) $90.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Plano
Ruben Saez, Md, MD
Hematology & Oncology — Payments: $117,913
Hematology & Oncology $117,913
Dr. Thuy Le, M.d, M.D
Hematology & Oncology — Payments: $22,323
Hematology & Oncology $22,323
Andrew Kovoor, Md, MD
Hematology & Oncology — Payments: $13,233
Hematology & Oncology $13,233
Virginia Kinsella, Md, MD
Hematology & Oncology — Payments: $13,129
Hematology & Oncology $13,129
Dr. Wendy Mahone-Johnson, Md, MD
Hematology & Oncology — Payments: $8,818
Hematology & Oncology $8,818
Dr. Nandita Rao, Md, MD
Hematology & Oncology — Payments: $4,337
Hematology & Oncology $4,337